Blue Capital Inc’s AbbVie ABBV Stock Holding History

Blue Capital Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$450K	Sell	1,790 -571	-24%	-$123K	0.29%	76
2026 Q1	$513K	Buy	2,361 +573	+32%	+$127K	0.34%	70
2025 Q4	$409K	Buy	1,788 +14	+0.8%	+$3.19K	0.29%	66
2025 Q3	$411K	Buy	1,774 +104	+6%	+$21.2K	0.31%	67
2025 Q2	$310K	Buy	+1,670	New	+$310K	0.22%	69
2024 Q4	$297K	Buy	+1,670	New	+$307K	0.21%	90

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Blue Capital Inc's ABBV Position: Q2 2026 in Review

Blue Capital Inc reduced its AbbVie (ABBV) stake by 24% in Q2 2026, selling an estimated $123K and leaving 1,790 shares worth $450K. The position accounts for 0.29% of the portfolio, ranked #76.

Blue Capital Inc first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $513K in Q1 2026. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Blue Capital Inc held 1,790 shares of AbbVie worth $450K as of Q2 2026.
Blue Capital Inc sold 571 AbbVie shares in Q2 2026, an estimated $123K.
AbbVie made up 0.29% of Blue Capital Inc's portfolio in Q2 2026, its #76 holding.
Blue Capital Inc first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Blue Capital Inc's AbbVie position peaked at $513K in Q1 2026.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Blue Capital Inc's 13F filing for Q2 2026, filed 11 Aug 2026.